Table 2.
Distribution of product doses according to the health claims and their reasons of adequacy
| Total supplements in which this health claim is given | Doses | Supplements in which this dosage is given for this health claim | Reason of adequacy* | |||
|---|---|---|---|---|---|---|
| Health claim | n | % | n | % | ||
| Improves strength | 70 | 41·9 % | Less than 3 g/d | 5 | 7·1 % | 2 |
| 3–3·9 g/d | 10 | 14·3 % | 3 | |||
| 4–4·9 g/d | 3 | 4·3 % | 3 | |||
| 5–5·9 g/d | 28 | 40 % | 3 | |||
| 6–6·9 g/d | 6 | 8·6 % | 3 | |||
| More than or equal to 7 g/d | 1 | 1·4 % | 3 | |||
| Dose by ranges | 6 | 8·6 % | 3 | |||
| Doses per loading and maintenance phases | 11 | 15·7 % | 3 | |||
| Increases muscle mass | 78 | 46·7 % | Less than 3 g/d | 6 | 7·7 % | 3 |
| 3–3·9 g/d | 10 | 12·8 % | 3 | |||
| 4–4·9 g/d | 3 | 3·8 % | 3 | |||
| 5–5·9 g/d | 29 | 37·2 % | 3 | |||
| 6–6·9 g/d | 5 | 6·4 % | 3 | |||
| More than or equal to 7 g/d | 2 | 2·6 % | 3 | |||
| Dose by ranges | 7 | 9 % | 3 | |||
| Doses per loading and maintenance phases | 16 | 20·5 % | 3 | |||
| Promotes cellular hydration | 13 | 7·8 % | 3–3·9 g/d | 3 | 23·1 % | 1 |
| 5–5·9 g/d | 5 | 38·5 % | 1 | |||
| Dose by ranges | 3 | 23·1 % | 1 | |||
| Doses per loading and maintenance phases | 2 | 15·4 % | 1 | |||
| Enhances physical performance | 122 | 73·1 % | Less than 3 g/d | 9 | 7·4 % | 2 |
| 3–3·9 g/d | 42 | 34·4 % | 3 and 4 | |||
| 4–4·9 g/d | 2 | 1·6 % | 2 | |||
| 5–5·9 g/d | 36 | 29·5 % | 2 | |||
| 6–6·9 g/d | 7 | 5·7 % | 2 | |||
| More than or equal to 7 g/d | 2 | 1·6 % | 2 | |||
| Dose by ranges | 11 | 9 % | 2 | |||
| Doses per loading and maintenance phases | 13 | 10·7 % | 2 | |||
| Improves recovery, prevents muscle fatigue or promotes muscle regeneration | 52 | 31·1 % | Less than 3 g/d | 7 | 13·5 % | 1 |
| 3–3·9 g/d | 7 | 13·5 % | 1 | |||
| 4–4·9 g/d | 2 | 3·8 % | 1 | |||
| 5–5·9 g/d | 17 | 32·7 % | 1 | |||
| 6–6·9 g/d | 2 | 3·8 % | 1 | |||
| More than or equal to 7 g/d | 1 | 1·9 % | 1 | |||
| Dose by ranges | 4 | 7·7 % | 1 | |||
| Doses per loading and maintenance phases | 12 | 23·1 % | 1 | |||
| Supports weight loss | 2 | 1·2 % | Less than 3 g/d | 1 | 50 % | 1 |
| 3–3·9 g/d | 1 | 50 % | 1 | |||
| Increases physical resistance | 20 | 12 % | Less than 3 g/d | 3 | 15 % | 1 |
| 3–3·9 g/d | 4 | 20 % | 1 | |||
| 5–5·9 g/d | 6 | 30 % | 1 | |||
| 6–6·9 g/d | 2 | 10 % | 1 | |||
| Dose by ranges | 1 | 5 % | 1 | |||
| Doses per loading and maintenance phases | 4 | 20 % | 1 | |||
| Increases power | 38 | 22·8 % | Less than 3 g/d | 1 | 2·6 % | 2 |
| 3–3·9 g/d | 5 | 13·2 % | 3 | |||
| 4–4·9 g/d | 1 | 2·6 % | 3 | |||
| 5–5·9 g/d | 16 | 42·1 % | 3 | |||
| 6–6·9 g/d | 3 | 7·9 % | 3 | |||
| More than or equal to 7 g/d | 2 | 5·3 % | 3 | |||
| Dose by ranges | 3 | 7·9 % | 3 | |||
| Doses per loading and maintenance phases | 7 | 18·4 % | 3 | |||
| Enhances physical performance in adults over the age of 55 | 2 | 1·2 % | 3–3·9 g/d | 1 | 50 % | 3 |
| 5–5·9 g/d | 1 | 50 % | 2 | |||
| Improves energy availability | 23 | 13·8 % | Less than 3 g/d | 1 | 4·3 % | 1 |
| 3–3·9 g/d | 4 | 17·4 % | 1 | |||
| 5–5·9 g/d | 9 | 39·1 % | 1 | |||
| 6–6·9 g/d | 2 | 8·7 | 1 | |||
| Dose by ranges | 1 | 4·3 % | 1 | |||
| Doses per loading and maintenance phases | 6 | 26·1 % | 1 | |||
| Promotes the replacement of creatine stores | 3 | 1·8 % | Less than 3 g/d | 2 | 66·7 % | 3 |
| Replenishes muscle glycogen stores | 2 | 1·2 % | Less than 3 g/d | 1 | 50 % | 3 |
| Dose by ranges | 1 | 50 % | 3 | |||
| Improves defenses or promotes greater protection | 2 | 1·2 % | 3–3·9 g/d | 1 | 50 % | 1 |
| Doses per loading and maintenance phases | 1 | 50 % | 1 | |||
| Promotes gastric emptying | 1 | 0·6 % | Doses per loading and maintenance phases | 1 | 100 % | 1 |
| Increases speed | 1 | 0·6 % | 5–5·9 g/d | 1 | 100 % | 1 |
| Improves brain capacities | 2 | 1·2 % | 3–3·9 g/d | 1 | 50 % | 1 |
| 5–5·9 g/d | 1 | 50 % | 1 | |||
| Promotes cardiovascular health | 2 | 1·2 % | Dose by ranges | 1 | 50 % | 1 |
| Doses per loading and maintenance phases | 1 | 50 % | 1 | |||
| Improves blood glucose | 1 | 0·6 % | Dose by ranges | 1 | 100 % | 1 |
| Helps the growth of bones and cartilage | 1 | 0·6 | 3–3·9 g/d | 1 | 100 % | 1 |
Reason: Number 1: Cause: it does not conform to the approved health claims about the CM; Proposal to modify: delete health claim. Number 2: Cause: it conforms to approved health claims but does not meet the recommended dosage of the product; Proposal to modify: modify product dosage protocol to 3 grams. Number 3: Cause: it conforms to the approved health claims and the correct dose established but does not specify the type of exercise performed; Proposal to modify: the claim effects must be specified for ‘sport events that require explosive, high-energy output activities especially of a repeated nature’(7). Number 4: Cause: it conforms to the approved health claim, specifying the appropriate recommended dose of the product and the effects of the supplement; Proposal to modify: Not modify or remove the health claim as it fits properly.